Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00365508 · OUTCOME

Rate of Compliance During the First 2 Weeks

Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking · Source last updated 2016-03-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
2 weeks

What was measured

Applied to use of the intervention (number of lozenges/day or number of patches used per week) not considering abstinence

Analysis population: Intent to treat

Groups in this outcome

Arm I

Participants apply a transdermal nicotine patch at 3 different time periods during weeks 3-14; a higher-dose patch is applied for weeks 3-8, a medium-dose patch is applied for weeks 9-10, and a lower-dose patch is applied for weeks 11-14.

Arm II

Participants receive one oral nicotine lozenge every 1-2 hours in weeks 3-8 (≥ 9 lozenges per day), one lozenge every 2-4 hours in weeks 9-11 (≥ 5 lozenges per day), and 1 lozenge every 4-8 hours in weeks 12-14 (≥ 3 lozenges per day).

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm I321
Arm II321

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I231Not reportedNot reportedNot reportedNot reported
Arm II87Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        231
      2. group Id
        OG001
        value
        87
denoms
  1. counts
    1. group Id
      OG000
      value
      321
    2. group Id
      OG001
      value
      321
    units
    Participants
description
Applied to use of the intervention (number of lozenges/day or number of patches used per week) not considering abstinence
groups
  1. description
    Participants apply a transdermal nicotine patch at 3 different time periods during weeks 3-14; a higher-dose patch is applied for weeks 3-8, a medium-dose patch is applied for weeks 9-10, and a lower-dose patch is applied for weeks 11-14.
    id
    OG000
    title
    Arm I
  2. description
    Participants receive one oral nicotine lozenge every 1-2 hours in weeks 3-8 (≥ 9 lozenges per day), one lozenge every 2-4 hours in weeks 9-11 (≥ 5 lozenges per day), and 1 lozenge every 4-8 hours in weeks 12-14 (≥ 3 lozenges per day).
    id
    OG001
    title
    Arm II
param Type
NUMBER
population Description
Intent to treat
reporting Status
POSTED
time Frame
2 weeks
title
Rate of Compliance During the First 2 Weeks
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice